Our data provide some additional support for the association of MAPT genetic variation with tau burden, and more broadly reinforces prior work suggesting roles for MAPT in the pathophysiology of Alzheimer’s disease and other tauopathies (Allen et al., 2014; Desikan et al., 2015; Heckman et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.